D 69 (Didanosine Delayed Release 200 mg)

Pill with imprint D 69 is White, Capsule-shape and has been identified as Didanosine Delayed Release 200 mg. It is supplied by Aurobindo Pharma.

Didanosine is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Didanosine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for D 69

Didanosine Delayed Release

Imprint:

D 69

Strength:

200 mg

Color:

White

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Nucleoside reverse transcriptase inhibitors (NRTIs)

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Aurobindo Pharma

Inactive Ingredients:

sodium starch glycolate type A potato
carboxymethylcellulose sodium
sodium lauryl sulfate
hypromellose 2910 (3 mPa.s)
magnesium silicate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
diethyl phthalate
silicon dioxide
gelatin
titanium dioxide
ferrosoferric oxide
shellac
Note: Inactive ingredients may vary.

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer